Workflow
Medpace(MEDP)
icon
Search documents
Medpace(MEDP) - 2022 Q2 - Earnings Call Transcript
2022-07-26 16:40
Medpace Holdings, Inc. (NASDAQ:MEDP) Q2 2022 Earnings Conference Call July 26, 2022 9:00 AM ET Company Participants Lauren Morris - Director of Investor Relations August Troendle - Chief Executive Officer Jesse Geiger - President Kevin Brady - Chief Financial Officer Conference Call Participants Dave Windley - Jefferies Christine Rains - William Blair Sandy Draper - Guggenheim Partners Paul Knight - KeyBanc Eric Coldwell - Robert W. Baird David Windley - Jefferies Operator Good day, ladies and gentlemen, an ...
Medpace(MEDP) - 2022 Q2 - Earnings Call Presentation
2022-07-26 12:54
| --- | --- | --- | --- | |-------|-------|-------|-------| | | | | | | | | | | FORWARD LOOKING STATEMENTS & NON-GAAP FINANCIAL MEASURES Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this presentation that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation, statements regarding our forecasted financia ...
Medpace(MEDP) - 2022 Q1 - Quarterly Report
2022-04-26 20:06
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Medpace Holdings, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Delaware 32-0434904 (I.R.S. Employer Identificat ...
Medpace(MEDP) - 2022 Q1 - Earnings Call Transcript
2022-04-26 17:58
Medpace Holdings, Inc. (NASDAQ:MEDP) Q1 2022 Earnings Conference Call April 26, 2022 9:00 AM ET Company Participants Lauren Morris ??? Director-Investor Relations August Troendle ??? Chief Executive Officer Jesse Geiger ??? President Kevin Brady ??? Chief Financial Officer Conference Call Participants Dave Windley ??? Jefferies Eric Coldwell ??? Baird Christine Rains ??? William Blair Paul Knight ??? KeyBanc Operator Good day, ladies and gentlemen, and welcome to the Medpace First Quarter 2022 Earnings Conf ...
Medpace(MEDP) - 2021 Q4 - Annual Report
2022-02-15 21:06
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 001-37856 Medpace Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 32-0434904 (State or other jurisdicti ...
Medpace(MEDP) - 2021 Q4 - Earnings Call Transcript
2022-02-15 18:40
Medpace Holdings, Inc. (NASDAQ:MEDP) Q4 2021 Earnings Conference Call February 15, 2022 9:00 AM ET Company Participants Lauren Morris - Associate Director, Investors Relations August Troendle - Chairman & CEO Jesse Geiger - President Kevin Brady - CFO & Treasurer Conference Call Participants John Kreger - William Blair & Company Donald Hooker - KeyBanc Capital Markets Operator Good day, ladies and gentlemen, and welcome to the Medpace Fourth Quarter and Full Year 2021 Earnings Conference Call. [Operator Ins ...
Medpace(MEDP) - 2021 Q4 - Earnings Call Presentation
2022-02-15 07:58
| --- | --- | --- | |-------|-------|-------| | | | | | | | | FORWARD LOOKING STATEMENTS & NON-GAAP FINANCIAL MEASURES Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this presentation that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation, statements regarding our forecasted financial results, the ant ...
Medpace(MEDP) - 2021 Q3 - Quarterly Report
2021-10-26 20:06
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 001-37856 5375 Medpace Way, Cincinnati, OH 45227 (Address of principal executive offices) (Zip Code) (513) 579-9911 (Registra ...
Medpace(MEDP) - 2021 Q3 - Earnings Call Transcript
2021-10-26 16:45
Medpace Holdings, Inc. (NASDAQ:MEDP) Q3 2021 Earnings Conference Call October 26, 2021 9:00 AM ET Company Participants Lauren Morris - Director of Investor Relations August Troendle - CEO Jesse Geiger - President Kevin Brady - CFO Conference Call Participants John Kreger - William Blair Donald Hooker - KeyBanc Dave Windley - Jefferies Operator Good day, ladies and gentlemen, and welcome to the Medpace Third Quarter 2021 Earnings Conference Call [Operator Instructions]. As a reminder, this call may be record ...
Medpace(MEDP) - 2021 Q2 - Quarterly Report
2021-07-27 20:40
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 001-37856 Medpace Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 32-0434904 (State or other jurisd ...